Patents by Inventor Yuanqiang Zou

Yuanqiang Zou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of in preventing and/or treating metabolic diseases
    Patent number: 11903981
    Abstract: Use of Anaerofustis stercorihominis in the prevention and/or treatment of metabolic diseases such as obesity, diabetes, atherosclerosis-related diseases, and cardiovascular diseases.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: February 20, 2024
    Assignee: BGI SHENZHEN
    Inventors: Ying Dai, Yuanqiang Zou, Liang Xiao
  • Intestinal bacteria and application thereof
    Patent number: 11484583
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: November 1, 2022
    Assignee: BGI SHENZHEN
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • Composition and uses thereof
    Patent number: 11376289
    Abstract: Provided are a composition and the uses thereof. Said composition comprises Megamonas funimormis and/or a metabolite thereof, as well as Anaerofustis stercorihominis and/or a metabolite thereof. Said composition can efficiently treat and prevent inflammation, specifically ulcerative colitis, and related diseases thereof by using a combination of Megamonas funimormis and Anaerofustis stercorihominis, and is safe, efficient, exhibits low toxicity and does not easily produce resistance.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: July 5, 2022
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • Use of in preventing and/or treating inflammation-related diseases
    Patent number: 11338000
    Abstract: Provided is a use of Butyribacter intestini in preventing and/or treating inflammation-related diseases. Specifically, in the present disclosure, it was firstly discovered that Butyribacter intestini has the function of preventing and/or treating inflammation-related diseases (for example, inflammatory bowel disease, such as ulcerative colitis, gastritis, and common enteritis; and rheumatoid arthritis).
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: May 24, 2022
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • Application of bacteroides cellulosityticus in preparing a preparation for preventing and/or treating lipid metabolism related diseases
    Patent number: 11273186
    Abstract: The present invention discloses an application of Bacteroides cellulosilyticus in preparing a preparation for preventing and/or treating lipid metabolism related diseases, such as atherosclerosis related diseases, cardiovascular diseases and obesity.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: March 15, 2022
    Assignee: BGI SHENZHEN
    Inventors: Zhuye Jie, Suisha Liang, Huihua Xia, Yuanqiang Zou, Liang Xiao, Huijue Jia
  • Use of Megamonas funiformis in preventing and/or treating metabolic diseases
    Publication number: 20220031770
    Abstract: Provided is a use of Megamonas funiformis in the prevention and/or treatment of metabolic diseases. Megamonas funiformis has the function of preventing and/or treating metabolic diseases (such as obesity, diabetes, atherosclerosis-related diseases, cardiovascular disease and hvperuricemia).
    Type: Application
    Filed: December 7, 2018
    Publication date: February 3, 2022
    Inventors: Ying Dai, Yuanqiang Zou, Liang Xiao
  • Biologically pure strain, composition including the same and method for treating ulcerative colitis
    Patent number: 11191790
    Abstract: Provided are a biologically pure Faecalibacterium butyricigenerans strain AF52-21 deposited under CGMCC Accession No. 1.5206 and a composition including the same and a carrier. A method for treating an inflammation-related disease in a subject in need thereof is also provided. The Faecalibacterium butyricigenerans is useful for treating ulcerative colitis and related disorders.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: December 7, 2021
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Wenbin Xue, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • USE OF ANAEROFUSTIS STERCORIHOMINIS IN PREVENTING AND/OR TREATING METABOLIC DISEASES
    Publication number: 20210353691
    Abstract: Use of Anaerofustis stercorihominis in the prevention and/or treatment of metabolic diseases such as obesity, diabetes, atherosclerosis-related diseases, and cardiovascular diseases.
    Type: Application
    Filed: December 7, 2018
    Publication date: November 18, 2021
    Inventors: Ying DAI, Yuanqiang ZOU, Liang XIAO
  • and applications thereof
    Patent number: 11160837
    Abstract: Provided are Megamonas funiformis and applications thereof. Specifically, the Megamonas funiformis has the effects for preventing and/or treating inflammation-related diseases, such as inflammatory bowel diseases (such as ulcerative enteritis, gastritis, and general enteritis) and cardiovascular diseases.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: November 2, 2021
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • Composition and uses thereof
    Publication number: 20210220415
    Abstract: Provided are a composition and the uses thereof. Said composition comprises Megamonas funimormis and/or a metabolite thereof, as well as Anaerofustis stercorihominis and/or a metabolite thereof. Said composition can efficiently treat and prevent inflammation, specifically ulcerative colitis, and related diseases thereof by using a combination of Megamonas funimormis and Anaerofustis stercorihominis, and is safe, efficient, exhibits low toxicity and does not easily produce resistance.
    Type: Application
    Filed: May 31, 2018
    Publication date: July 22, 2021
    Inventors: Yuanqiang Zou, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • Intestinal bacteria butyribacterintestini and application thereof
    Patent number: 11033614
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: June 15, 2021
    Assignee: BGI SHENZHEN
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • INTESTINAL BACTERIA BUTYRIBACTERINTESTINI AND APPLICATION THEREOF
    Publication number: 20210170009
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 10, 2021
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • USE OF BUTYRlBACTER INTESTINI IN PREVENTING AND/OR TREATING INFLAMMATION-RELATED DISEASES
    Publication number: 20210085730
    Abstract: Provided is a use of Butyribacter intestini in preventing and/or treating inflammation-related diseases. Specifically, in the present disclosure, it was firstly discovered that Butyribacter intestini has the function of preventing and/or treating inflammation-related diseases (for example, inflammatory bowel disease, such as ulcerative colitis, gastritis, and common enteritis; and rheumatoid arthritis).
    Type: Application
    Filed: December 8, 2017
    Publication date: March 25, 2021
    Inventors: Yuanqiang ZOU, Liang XIAO, Xiaoping LI, Jinghong YU, Chuan LIU
  • MEGAMONAS FUNIFORMIS AND APPLICATIONS THEREOF
    Publication number: 20200384039
    Abstract: Provided are Megamonas funiformis and applications thereof. Specifically, the Megamonas funiformis has the effects for preventing and/or treating inflammation-related diseases, such as inflammatory bowel diseases (such as ulcerative enteritis, gastritis, and general enteritis) and cardiovascular diseases.
    Type: Application
    Filed: September 15, 2017
    Publication date: December 10, 2020
    Inventors: Yuanqiang ZOU, Liang XIAO, Xiaoping LI, Jinghong YU, Chuan LIU
  • and application thereof
    Patent number: 10806759
    Abstract: Provided are Christensenella intestinihominis and an application thereof, specifically, use of Christensenella intestinihominis in treating and preventing obesity and related diseases thereof. Also provided are a composition for treating and preventing obesity and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight and/or blood lipid.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: October 20, 2020
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Wenbin Xue, Mei Lv, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • Faecalibacterium longum and application thereof
    Patent number: 10799540
    Abstract: Provided are Faecalibacterium longum and an application thereof, specifically, use of Faecalibacterium longum in treating and preventing diabetes and related diseases thereof. Also provided are a composition for treating and preventing diabetes and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight, fasting plasma glucose and/or blood lipid, and improving glucose tolerance.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: October 13, 2020
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Wenbin Xue, Liang Xiao, Chuan Liu
  • Application of Bacteroides Cellulosityticus in Preparing a Preparation for Preventing and/or Treating Lipid Metabolism Related Diseases
    Publication number: 20200230181
    Abstract: The present invention discloses an application of Bacteroides cellulosilyticus in preparing a preparation for preventing and/or treating lipid metabolism related diseases, such as atherosclerosis related diseases, cardiovascular diseases and obesity.
    Type: Application
    Filed: August 29, 2017
    Publication date: July 23, 2020
    Inventors: Zhuye Jie, Suisha Liang, Huihua Xia, Yuanqiang Zou, Liang Xiao, Huijue Jia
  • Application of Alistipes shahii in preparing a composition for preventing and/or treating lipid metabolism related diseases
    Publication number: 20200197448
    Abstract: The present invention discloses an application of Alistipes shahii in preparing a composition for preventing and/or treating lipid metabolism related diseases, for example but not limited to, atherosclerosis related diseases, cardiovascular diseases and obesity.
    Type: Application
    Filed: August 29, 2017
    Publication date: June 25, 2020
    Inventors: Zhuye Jie, Suisha Liang, Huihua Xia, Yuanqiang Zou, Liang Xiao, Huijue Jia
  • CHRISTENSENELLA INTESTINIHOMINIS AND APPLICATION THEREOF
    Publication number: 20190282633
    Abstract: Provided are Christensenella intestinihominis and an application thereof, specifically, use of Christensenella intestinihominis in treating and preventing obesity and related diseases thereof. Also provided are a composition for treating and preventing obesity and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight and/or blood lipid.
    Type: Application
    Filed: September 6, 2016
    Publication date: September 19, 2019
    Inventors: Yuanqiang ZOU, Wenbin XUE, Mei LV, Liang XIAO, Xiaoping LI, Jinghong YU, Chuan LIU
  • BIOLOGICALLY PURE FAECALIBACTERIUM BUTYRICIGENERANS STRAIN, COMPOSITION INCLUDING THE SAME AND METHOD FOR TREATING INFLAMMATION-RELATED DISEASE
    Publication number: 20190240265
    Abstract: Provided are a biologically pure Faecalibacterium butyricigenerans strain AF52-21 deposited under CGMCC Accession No. 1.5206 and a composition including the same and a carrier. A method for treating an inflammation-related disease in a subject in need thereof is also provided.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 8, 2019
    Inventors: Yuanqiang ZOU, Wenbin XUE, Liang XIAO, Xiaoping LI, Jinghong YU, Chuan LIU